Endi Bio

Founded in 2011, Endi Bio is mainly engaged in large-scale birth defect detection services and industrialized development of precision medical treatment for tumors. It has independently developed and formed a number of fist-shaped products such as personalized genetic testing for cancer and non-invasive prenatal genetic testing for Youxin 'an, and successfully built an all-round integrated testing service technology platform. Based in Beijing, it has spread all over the country, and its business has spread all over more than 30 provinces and cities in China. It can realize batch sample detection and massive data analysis and processing, and has world-class gene sequencing hardware equipment and corresponding biological information analysis capability. Focus on creating modern medical health solutions integrating disease prevention, prediction, detection, interpretation and intervention.